Comparison of atrial fibrillation predictors in patients with acute coronary syndrome using ticagrelor or clopidogrel

BACKGROUND/AIM: Ticagrelor is a drug widely used in patients with acute coronary syndromes (ACS) that specifically increases the plasma level of adenosine, which is likely to cause atrial fibrillation (AF). Therefore, in this study we aimed to investigate the electrocardiographic and echocardiograph...

Descripción completa

Detalles Bibliográficos
Autores principales: ALGÜL, Engin, SUNMAN, Hamza, DURAL, Muhammet, GULİYEV, İlkin, AKER, Mert, FELEKOĞLU, Mehmet Ali, ERAT, Mehmet, TULMAÇ, Murat, AÇIKEL, Sadık, ÇİMEN, Tolga
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Scientific and Technological Research Council of Turkey 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7018378/
https://www.ncbi.nlm.nih.gov/pubmed/31549494
http://dx.doi.org/10.3906/sag-1903-188

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7018378/
https://www.ncbi.nlm.nih.gov/pubmed/31549494
http://dx.doi.org/10.3906/sag-1903-188

Ejemplares similares